Insta
Covid-19 vaccine - representative image (Twitter)
Within two weeks, pharmaceutical company Zydus Cadila is set to apply for a license to administer the doses of its Covid-19 vaccine candidate to children aged between 12-18 years as it is currently undertaking tests for the same.
“Not only Covaxin is conducting child trials—and they will not take long because they are all immunogenic trials—but also Zydus vaccine is already being tested on children,” NITI Aayog (health) member Dr VK Paul was quoted in a report by the Hindustan Times.
Paul added, “So when Zydus comes for licensure, hopefully in the next two weeks, maybe we will also have enough data on the view whether that vaccine can be given to children.”
The senior government official mentioned that around 25-26 crore doses of the vaccines would be required to vaccinate children falling between the 12-18 age category. Hence, Paul asserted that they would have to consider this sheer volume to subsequently strategize and make a call based on the availability of the vaccines.
Meanwhile, Zydus Cadila is conducting the phase 3 trial protocol for ZyCov-D, its vaccine candidate, by administering three intradermal doses in 30,000 volunteers. The company has mentioned that its vaccine was immunogenic, well-tolerated and safe in the Adaptive Phase I/II clinical trials.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest